DOI: https://doi.org/10.21203/rs.2.10084/v2
Background: Evidence on the add-on effect of Kinesiotape (KT) on acupuncture for treating ankle sprains remains insufficient. We assessed the add-on effect of KT on ankle sprains by comparing acupuncture combined with KT (AcuKT) with acupuncture alone in patients with acute lateral ankle sprain (ALAS).
Methods: This study was a multicenter, randomized, controlled clinical trial that included a per-protocol analysis of the add-on effect of KT on ALAS. The randomization was software-based and only the assessors were blinded. Sixty participants (20 each from three centers) with Grade I or II ALAS were randomly assigned to acupuncture (n=30) or AcuKT (n=30) group. Both groups received acupuncture treatment once daily, 5 days per week for 1 week. The AcuKT group received additional KT treatment. Visual analog scale (VAS) scores for pain and Foot and Ankle Outcome Score (FAOS) were obtained, and edema measurements were performed at baseline (Week 0), at the end of the intervention (Week 1), and at 4 weeks after intervention (Week 5). The European Quality of Life Five Dimension-Five Level Scale (EQ-5D-5L) measurements were conducted at Week 0, Week 1, Week 5, and Week 26 after the intervention. The number of recurrent ankle sprains was determined at 4, 8, 12, and 26 weeks after the intervention.
Results: Fifty-six patients with ALAS completed the trial (AcuKT group, 27; acupuncture group, 29). There were significant changes in VAS score (AcuKT: p<0.001; acupuncture: p<0.001), FAOS (AcuKT: p<0.001; acupuncture: p<0.001), and EQ-5D-5L measurements (AcuKT: p<0.001; acupuncture: p<0.001) within both groups. There were no significant differences between groups in terms of any outcome and in a subanalysis based on symptom severity.
Conclusions: These results indicate that AcuKT did not show positive add-on effects of KT on acupuncture in terms of pain reduction, edema, recovery of function, activities of daily living, quality of life, and relapse of ALAS.
Acute ankle sprain is an acute injury of one or more ankle ligaments [1]. The most frequent ankle injury is ligament sprain, with up to 85% cases involving the lateral ligament complex [2]. Ankle sprains are commonly considered to be benign injuries that resolve quickly [3]. However, if not managed appropriately, patients may experience recurrent instability, chronic pain, osteochondral lesions of the talus, premature osteoarthritis, and other significant long-term disabilities [4]. Ankle sprain has a high incidence, with a consequent high prevalence of persistent problems that lead to high costs to the society because of increased use of healthcare resources and an inability to work [5].
The three major types of treatments for ankle sprain are surgery, immobilization with a plaster cast or splint, and functional treatment with bandage, tape, different brace, or balance training [6]. Management of acute ankle sprains typically involves rest, ice compression, elevation, and functional rehabilitation. In more severe cases, the ankle is normally immobilized for a few days, and the patient must use crutches to avoid weight bearing on the injured ankle [7].
In 2017, ankle sprain was the fifth most common reason for visits to Korean medicine clinics, and 1 million Korean patients with ankle sprain received Korean medicine treatment [8]. In addition to conventional treatments for ankle sprain, complementary and alternative therapies such as acupuncture, herbs, cupping therapy, taping, and chuna were used to relieve pain, reduce swelling, and help the body restore damaged tissue in cases of ankle sprain [9].
Kinesio tape (KT), developed in the 1970s by the Japanese chiropractor, Dr Kenso Kase, is an elastic therapeutic tape used for the treatment of sports injuries and a variety of other conditions [10]. KT differs from the traditional white athletic tape because of the wave-like grain design on the adhesive surface of KT [11]. First, the specialized grain and elasticity of KT provide a tensile force to the skin and are purported to lift the fascia and soft tissue, allowing mobility while providing therapeutic benefits [12]. Second, KT is air-permeable and water resistant and can be worn for several days without removal [13]. The application of KT has been suggested to result in the improvement of muscle contractility by supporting weakened muscles, decreasing inflammation and pain by increasing lymph and blood flow, and increasing joint range of motion by adjusting the misalignment of muscle fibers, myofascia, and joints [14,15]. KT may also assist in ankle sprain management by reducing pain, altering muscle function, improving circulation, enhancing proprioception, and repositioning subluxed joints [16].
Although KT is mainly used with acupuncture for the treatment of ankle sprain in Korean medicine, evidence regarding the add-on effect of KT on acupuncture in ankle sprain is insufficient. Therefore, this study was performed to investigate the add-on effect of KT on acupuncture in acute lateral ankle sprain (ALAS) by comparing acupuncture combined with KT (AcuKT) with acupuncture alone in patients with ALAS.
This study followed the standard protocol items of the Recommendations for Interventional Trials (SPIRIT) and Consolidated Standards of Reporting Trials (CONSORT) statement. The detailed methods of this study have been reported previously [17].
This study was a prospective, outcome assessor-blinded, multicenter, randomized, controlled trial with a 1:1 allocation ratio. Participants (n = 20 from each of the three centers) who met the inclusion criteria were randomly allocated to either the acupuncture group (n = 10 from each of the three centers) or AcuKT group (n = 10 from each of the three centers). Both groups received acupuncture treatment once daily, 5 days per week (excluding Saturday and Sunday) for 1 week, and the AcuKT group also received the ankle meridian tendino-musculature and eight-shape form of KT treatment. Outcome measures were determined at baseline (Week 0), 1 week after the first intervention (Week 1), and 4 weeks after completion of the intervention (Week 5). The number of recurrent ankle sprains was determined at 4, 8, 12, and 26 weeks after the completion of the intervention. The study design is summarized in Fig. 1.
Fig.1. Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement.
The figure shows the enrollment, interventions, and data collection protocols.
This study was conducted in accordance with the Declaration of Helsinki and the protocol of this study (ver.1.0) was approved by the Institutional Review Board (IRB) of DongShin University Gwangju Korean Medicine Hospital (DSGOH–039; approval date: March 20, 2017), DongShin University Mokpo Oriental Hospital (DSMOH–002; approval date: March 27, 2017), and KyungHee Korean Medicine Hospital (KOMCIRB–161014-HR–057; approval date: April 28, 2017) before the trial began. This trial was registered at the Clinical Research Information Service (cris.nih.go.kr; registration number: KCT0002257; registration date: February 27, 2017). The purpose and potential risks of this study were fully explained to the participants. All participants provided written informed consent before participating in this study.
Participants were recruited at three hospitals in the Republic of Korea as follows: DongShin University Gwangju Korean Medicine Hospital, DongShin University Mokpo Oriental Hospital, and KyungHee Korean Medicine Hospital. This study was publicized via local newspapers, the internet, and posters in communities and hospitals. The clinical research coordinator continuously monitored the medical conditions of enrolled participants to maximize adherence to intervention protocols.
Patients aged >19 years; (2) those who had sustained a Grade I or II ALAS within the past 7 days; and (3) those who voluntarily signed the informed consent form were included in the study. Grade I ankle sprain was defined as no loss of function, no ligamentous laxity (i.e., negative anterior drawer and talar tilt tests), little or no hemorrhaging, no point tenderness, total ankle motion reduced by ≤5°, and swelling of ≤0.5 cm. Some loss of function, a positive anterior drawer test (anterior talofibular ligament involvement), a negative talar tilt test (no calcaneofibular ligament involvement), hemorrhaging, point tenderness, decreased total ankle motion by >5° but <10°, and swelling of >0.5 cm but <2.0 cm were characteristics of Grade II ankle sprain [18].
Subjects whose general condition was unsatisfactory or who were unfit for acupuncture or AcuKT therapies were excluded. The detailed exclusion criteria were as follows: (1) fracture as confirmed by radiography, or a Grade III ankle sprain; near-total loss of function, positive anterior drawer and talar tilt tests, hemorrhaging, extreme point tenderness, total ankle motion reduction by >10°, or swelling >2.0 cm (considered to as Grade III ankle sprain) [18]; (2) history of fracture in the same ankle during the previous year; (3) a wound or skin disease at the KT attachment site; (4) serious disease (e.g., cancer, kidney disease, liver disease, disease of central nervous system, dementia, blood clotting disturbance such as hemophilia, etc.); (5) motor or sensory disturbance caused by a nervous system disorder in the leg with the sprain; and (6) pregnancy or breastfeeding.
After baseline measurements were obtained, SPSS version 20.0 (SPSS Inc., Chicago, IL, USA) was used to assign a serial number to the 60 research volunteers and to randomly allocate 30 of them to each group. The serial number codes were inserted into opaque envelopes that were sealed and kept in a double-locked cabinet, and opened in the presence of the patient and a guardian.
We could only adopt a single outcome assessor-blinding approach because sham treatment was impossible due to the characteristics of KT application, which included attachment to the skin. During the study, the assessor was blinded to group assignments, and data analysts without conflicts of interest were involved in this study.
A clinical research coordinator generated the allocation sequence, enrolled the participants, and assigned participants to interventions.
Acupuncture treatment was conducted as follows: Only sterile, stainless, disposable acupuncture needles (size 0.25×30 mm; Dong Bang Acupuncture, Inc., Boryeong, Republic of Korea; product no. A84010.02) with guide-tubes were vertically inserted into ST36, ST41, BL60, BL62, KI3, KI6, GB39, and GB40 acupuncture points on the affected side [9]. The depth of insertion was 10 to 20 mm, depending on the location of the needle [19]. After insertion, the needles were left in position for 15 min in every session. Manual stimulation and electroacupuncture were not applied.
KT treatment was conducted after acupuncture treatment by the same practitioner. The KT treatment method was conducted as follows. First, an I-shaped tape was applied from ST42 to ST36 over the tibialis anterior muscle (Fig. 2①–③). Second, an I-shaped tape was applied from GB42 to GB34 over the peroneus longus and brevis muscles (Fig.2④–⑥). Third, an I-shaped tape was applied from the abductor digiti minimi muscle and was wrapped around the ankle in a figure-of-eight shape to the abductor halluces muscle, covering both the medial and lateral malleoli (Fig.2⑦–⑨)[20].The NK–50 kinesiology tape was used (width 50 mm, thickness 0.5 mm; Nitto Denko Medical MFG. Co., Ltd., Miyagi, Japan; product no. B07090.02). The tape was laid on the skin without being stretched, to prevent skin problems. The KT treatment was applied daily after the removal of the tape applied the previous day, even in cases in which the patient did not complain of itchiness [21].
Fig.2. Application of Kinesiotape.
The primary outcome was the visual analog scale (VAS) score for pain, and the secondary outcomes were Foot and Ankle Outcome Scores (FAOS), edema, European Quality of Life Five-Dimension-Five-Level Scale (EQ–5D–5L) scores, and the number of recurrent ankle sprains. VAS, FAOS, and edema measurements were performed at baseline (Week 0; before intervention), 5 days after the first intervention (Week 1; at the end of the intervention), and 4 weeks after the completion of the intervention (Week 5). EQ–5D–5L measurements were conducted at baseline, 5 days after the first intervention, 4 weeks after the completion of intervention, and 26 weeks after the completion of intervention (Week 27). The numbers of recurrent ankle sprains were assessed at 4(Week 5),8(Week 9),12(Week 13), and 26 weeks after the completion of the intervention.
The primary outcome was change in pain severity measured using VAS-pain. The VAS is a 10-cm-long straight line marked at each end with the anchor labels “no pain” and “pain as bad as it could be” [22]. Participants were asked to mark on the line at a point representing the severity of their pain. Scores were recorded in millimeters, with a total score range of 0–100 mm [23].
The FAOS is a region-specific instrument that is intended to evaluate symptoms and functional limitation in individuals with generalized foot and ankle disorders. It is composed of the following five subscales: pain (9 items), other symptoms (7 items), activities of daily living (17 items), sports and recreational activities (5 items), and foot and ankle-related quality of life (4 items). The subscales are scored separately using a Likert response format, with higher scores indicating higher levels of function [24].
Edema was measured in centimeters via the figure-of-eight method. The measuring tape was applied across the following landmarks in a figure-of-eight fashion as follows: (1) navicular tuberosity; (2) distal tip of the lateral malleolus; (3) distal tip of the medial malleolus; and (4) base of the fifth metatarsal. The resulting value was compared with the corresponding value for the healthy ankle [25].
The EQ–5D is a generic instrument for assessing health-related quality of life. It is based on a descriptive system that defines health in terms of five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has three response categories corresponding to no problems, some problems, and extreme problems. The EQ–5D–5L is a new version of EQ–5D that includes five levels of severity in each of the existing five EQ–5D dimensions [26].
Ankle sprain recurrence was defined as an ankle sprain occurring as a result of sports participation or other daily activities, and which caused one or more of the following: (1) stoppage of the sports activity; (2) limited participation in the next planned sports activity; (3) inability to go to work/school the next day; or (4) the need for medical attention (ranging from onsite care administered by a general practitioner to personal care administered by a sports physician) [27].
In accordance with a previous study [28], we established the number of groups as two and the effect size as 0.906, with a one-sided alpha level of 0.025 and a statistical power of 0.8. Based on these parameters, the required sample size was 42 (21 per group). Estimating a maximum dropout rate of 30%, we determined that a total of 60 participants were required. The sample size calculation was detailed in our study protocol [17].
With the approval of the IRB, the statistical analysis was revised from the study protocol. We performed per-protocol analyses for the assessment of efficacy and a supplementary full analysis set. Missing values were implemented by the last observation carried forward method. We compared the results of PP analyses and analyses of the FA set. If there was a significant difference between the PP and FA groups, the cause was reviewed and reflected during efficacy assessment. Analysis was performed by blinded biostatisticians with SPSS version 20.0 software (SPSS Inc., Chicago, IL, USA) using two-sided significance tests with a 5% significance level. Continuous variables are presented as means and standard deviations (SD), and categorical variables are presented as count frequencies and percentages.
Baseline data were collected and compared using the independent t-test, χ2 test, and Fisher’s exact test. Differences between all outcome value changes in the two groups were compared via Wilcoxon signed-rank test and repeated measures ANOVA (Friedman tests). Values of VAS, edema, EQ–5D–5L, and FAOS were compared by repeated-measures analysis of variance (ANOVA) across two to three testing time points (Week 0, Week 1, and Week 5). Differences between two groups of outcome value changes (Week 0 vs. Week 1 and Week 0 vs. Week 5) were compared via the Mann–Whitney U-test (nonparametric test). Differences between two groups in terms of number of recurrent ankle sprains (Week 5, Week 9, Week 13, and Week 27) were compared by the Mann–Whitney U-test (nonparametric test). In accordance with the severity of ankle sprain, participants were divided into Grade I and Grade II groups. A subanalysis was conducted to investigate the differences in changes in VAS, edema, EQ–5D–5L, and FAOS (Week 0 vs. Week 1 and Week 0 vs. Week 5) between the two groups in the Grade I and Grade II group.
We recruited participants between April 28, 2017, and October 15, 2018. During the study period, 840 patients were assessed for eligibility and 780 were excluded. Sixty patients were included in this study and were randomly assigned to an acupuncture group (n = 30) and an AcuKT group (n = 30). Three patients did not complete the treatment in the AcuKT group, while one did not complete treatment in the acupuncture group. The results of the per-protocol analysis for the assessment of efficacy were not different from those of the full analysis set. Thus, data for 56 ankle sprain patients (AcuKT group, n = 27; acupuncture group, n = 29) were used in the final analysis (Fig. 3).
Fig.3. CONSORT 2010 flow diagram.
The baseline demographic characteristics and study variables of the 56 ankle sprain patients in the two groups are presented in Table 1. No significant differences in the baseline demographic characteristics and study variables were detected between the two groups (P>0.05; Table 1).
|
Table 1. Homogeneity tests for baseline demographic characteristics and study variables of 56 patients with acute lateral ankle sprain |
||||
|
Dependent Variables |
AcuKT (n=27) |
Acupuncture (n=29) |
t or x²(P) |
|
|
Mean(SD) or n(%) |
Mean(SD) or n(%) |
|||
|
Age (y) |
39.81(15.02) |
39.28(14.23) |
0.14(.891)* |
|
|
Gender (Female) |
17(63.0%) |
20(69.0%) |
0.23(.635)ǂ |
|
|
Lesion side (Rt) |
14(51.9%) |
19(65.5%) |
1.09(.299) ǂ |
|
|
Sprains injury rating (Grade 1) |
14(46.7) |
16(55.2) |
0.27(.599) ǂ |
|
|
Duration |
3.30(1.92) |
3.72(1.62) |
0.90(.370) ǂ |
|
|
BMI |
24.78(3.74) |
24.36(3.55) |
0.44(.663)* |
|
|
VAS of pain |
4.11±1.40 |
4.79±2.02 |
1.44(.154)* |
|
|
Degree of edema |
0.56±0.64 |
0.48±0.78 |
-0.38(.706)* |
|
|
EQ-5D-5L |
9.41±2.37 |
9.90±2.83 |
0.70(.488)* |
|
|
FAOS |
322.11±65.78 |
318.32±76.72 |
-0.21(.838)* |
|
|
FAOS Symptom/Rigidity |
68.01±14.46 |
69.91±16.52 |
0.46(.650)* |
|
|
FAOS ache |
69.39±15.52 |
68.24±17.18 |
-0.26(.794)* |
|
|
FAOS Function, everyday life |
75.93±14.75 |
77.38±16.17 |
0.35(.729)* |
|
|
FAOS Features,Sports/Leisure |
50.56±25.34 |
52.17±19.99 |
0.23(.818)* |
|
|
FAOS Quality of life |
58.22±21.23 |
50.63±25.35 |
-1.19(.233)* |
|
*, t-test; ǂ, x²-test
After 1 week of intervention, we observed significant improvements in the AcuKT group and acupuncture group (changes in VAS-pain, EQ–5D–5L, Total FAOS, FAOS Symptom/Rigidity, FAOS Ache, FAOS Function everyday life, FAOS Features Sports/Leisure, and FAOS Quality of life scores) (Table 2).
Table 2.Changes in outcome measures (Week 0 vs. Week 1, Week 0 vs. Week 5) after treatment completion between patients who received AcuKT (n=27) and those who received acupuncture (n=29) for acute lateral ankle sprain
|
Groups |
Dependent Variables |
Week 0 (M±SD) |
Week 1 (M±SD) |
Week 5 (M±SD) |
Difference (w1-w0) |
Z (P) * |
Difference (w5-w0) |
Z (P) * |
x² (P) ǂ |
|
AcuKT Group (n=27) |
Degree of edema |
0.56±0.64 |
0.26±1.59 |
0.19±0.43 |
-0.30±0.54 |
-2.53 (.011) |
-0.36±0.68 |
-2.43 (.015) |
4.87 (.088) |
|
VAS of pain |
4.11±1.40 |
1.89±1.44 |
0.97±1.04 |
-2.21±1.58 |
-4.42 (<.001) |
-3.14±1.34 |
4.55 (<.001) |
44.83 (<.001) |
|
|
TOTAL EQ-5D-5L |
9.41±2.37 |
7.19±1.94 |
6.04±1.45 |
-2.22±3.06 |
-3.29 (.001) |
-3.37±2.68 |
4.02 (<.001) |
30.42 (<.001) |
|
|
TOTAL FAOS |
322.11±65.78 |
402.44±65.785 |
439.65±50.27 |
80.33±62.74 |
-4.54 (<.001) |
117.54±61.29 |
4.54 (<.001) |
45.66 (<.001) |
|
|
FAOS Symptom/Rigidity |
68.01±14.46 |
81.44±12.16 |
89.01±10.97 |
13.43±12.82 |
-3.92 (<.001) |
21.00±16.70 |
4.11 (<.001) |
28.95 (<.001) |
|
|
FAOS ache |
69.39±15.52 |
84.41±11.75 |
91.92±8.96 |
15.02±13.59 |
-4.07 (<.001) |
22.53±14.57 |
4.46 (<.001) |
41.16 (<.001) |
|
|
FAOS Function, everyday life |
75.93±14.75 |
90.03±10.32 |
95.00±6.71 |
14.09±13.20 |
-4.14 (<.001) |
19.07±13.90 |
4.36 (<.001) |
33.88 (<.001) |
|
|
FAOS Features,Sports/Leisure |
50.56±25.34 |
74.27±17.24 |
84.43±14.57 |
23.72±20.09 |
-4.05 (<.001) |
33.87±20.47 |
4.55 (<.001) |
41.57 (<.001) |
|
|
FAOS Quality of life |
58.22±21.23 |
72.29±23.30 |
79.28±16.16 |
14.07±22.22 |
-2.96 (.003) |
21.06±21.43 |
3.94 (<.001) |
18.37 (<.001) |
|
|
|
Degree of edema |
0.48±0.78 |
0.24±0.74 |
0.26±0.57 |
-0.24± 0.64 |
-1.94 (.052) |
-0.22±0.60 |
-1.31 (.191) |
5.48 (.065) |
|
Acupunture group (n=29) |
VAS of pain |
4.79±2.02 |
2.31±1.86 |
1.58±1.89 |
-2.47±1.86 |
-4.53 (<.001) |
-3.21±1.99 |
4.46 (<.001) |
39.41 (<.001) |
|
TOTAL EQ-5D-5L |
9.90±2.83 |
7.76±2.32 |
7.00±2.19 |
-2.14±2.50 |
-4.00 (<.001) |
-2.90±2.54 |
-4.22 (<.001) |
34.24 (<.001) |
|
|
TOTAL FAOS |
318.32±76.72 |
385.00±77.90 |
416.25±74.24 |
66.67±49.51 |
-4.33 (<.001) |
97.92±73.06 |
-4.27 (<.001) |
31.74 (<.001) |
|
|
FAOS Symptom/Rigidity |
69.91±16.52 |
82.10±13.94 |
86.30±13.51 |
12.19±12.38 |
-3.79 (<.001) |
16.39±14.59 |
-4.13 (<.001) |
21.56 (<.001) |
|
|
FAOS Ache |
68.24±17.18 |
80.90±16.14 |
86.17±16.33 |
12.66±11.09 |
-4.20 (<.001) |
17.93±15.55 |
-4.15 (<.001) |
26.26 (<.001) |
|
|
FAOS Function, everyday life |
77.38±16.17 |
87.06±13.84 |
92.37±10.98 |
9.68 11.05 |
-3.77 (<.001) |
14.99±14.05 |
-4.43 (<.001) |
28.71 (<.001) |
|
|
FAOS Features,Sports/Leisure |
52.17±19.99 |
70.52±20.63 |
79.66±17.83 |
18.35 18.75 |
-3.88 (<.001) |
27.49±22.91 |
-4.23 (<.001) |
30.14 (<.001) |
|
|
FAOS Quality of life |
50.63±25.35 |
64.41±24.78 |
71.76±24.30 |
13.79±21.42 |
-3.11 (<.001) |
21.13±22.93 |
-3.80 (<.001) |
20.33 (<.001) |
*, Wilcoxon signed-rank test; ǂ, Repeated measures ANOVA (Friedman test)
Repeated measures ANOVA showed no significant interaction between time and group with respect to all study variables (Table 3).
|
Table 3. Results of repeated-measures ANOVA for the outcomes of treatment between patients who received AcuKT (n=27) and those who received acupuncture (n=29) for acute lateral ankle sprain |
||||||||||
|
Dependent Vatiables |
Group (n) |
Week 0 (M±SD) |
Week 1 (M±SD) |
Week 5 (M±SD) |
Source |
SS |
df |
Mean Square |
F |
p |
|
VAS of pain |
Acu (n=29) |
4.79±2.02 |
1.62±0.62 |
1.58±1.89 |
Time |
303.30 |
1.66 |
182.28 |
125.67 |
<.001 |
|
AcuKT (n=27) |
4.11±1.40 |
1.56±0.64 |
0.97±1.04 |
Group*Time |
0.50 |
1.66 |
0.30 |
0.21 |
.774 |
|
|
Degree of edema |
Acu (n=29) |
0.48±0.78 |
2.31±1.86 |
0.26±0.57 |
Time |
2.97 |
2 |
1.48 |
8.98 |
<.001 |
|
AcuKT (n=27) |
0.56±0.64 |
1.90±1.45 |
0.19±0.43 |
Group*Time |
0.14 |
2 |
0.07 |
0.41 |
.662 |
|
|
TOTAL EQ-5D-5L |
Acu (n=29) |
9.90±2.83 |
7.76±2.32 |
7.00±2.19 |
Time |
288.60 |
1.61 |
179.50 |
49.33 |
<.001 |
|
AcuKT (n=27) |
9.41±2.37 |
7.19±1.94 |
6.04±1.45 |
Group*Time |
1.79 |
1.61 |
1.11 |
0.305 |
.689 |
|
|
TOTAL FAOS |
Acu (n=29) |
318.32±76.72 |
385.00±77.90 |
416.25±74.24 |
Time |
338926.08 |
1.56 |
169463.04 |
107.76 |
<.001 |
|
AcuKT (n=27) |
322.11±65.78 |
402.44±60.10 |
439.65±50.27 |
Group*Time |
2827.45 |
1.56 |
18100.11 |
0.90 |
.389 |
|
|
FAOS Symptom/Rigidity |
Acu (n=29) |
69.91±16.52 |
82.10±13.94 |
86.30±13.51 |
Time |
10221.41 |
1.69 |
6064.62 |
58.88 |
<.001 |
|
AcuKT (n=27) |
68.01±14.46 |
81.44±12.16 |
89.01±10.97 |
Group*Time |
159.70 |
1.69 |
94.76 |
0.92 |
.388 |
|
|
FAOS ache |
Acu (n=29) |
68.24±17.18 |
80.90±16.14 |
86.17±16.33 |
Time |
11962.24 |
1.53 |
7832.55 |
78.00 |
<.001 |
|
AcuKT (n=27) |
69.39±15.52 |
84.41±11.75 |
91.92±8.96 |
Group*Time |
147.87 |
1.53 |
96.82 |
0.96 |
.365 |
|
|
FAOS Function, everyday life |
Acu (n=29) |
77.38±16.17 |
87.06±13.84 |
92.37±10.98 |
Time |
8533.93 |
1.57 |
5428.96 |
61.82 |
<.001 |
|
AcuKT (n=27) |
75.93±14.75 |
90.03±10.32 |
95.00±6.71 |
Group*Time |
168.90 |
1.57 |
107.45 |
1.22 |
.292 |
|
|
FAOS Features,Sports/ Leisure |
Acu (n=29) |
52.17±19.99 |
70.52±20.63 |
79.66±17.83 |
Time |
27533.87 |
1.55 |
17764.44 |
81.35 |
<.001 |
|
AcuKT (n=27) |
50.56±25.34 |
74.27±17.24 |
84.43±14.57 |
Group*Time |
329.04 |
1.55 |
212.29 |
0.97 |
.363 |
|
|
FAOS Quality of life |
Acu (n=29) |
50.63±25.35 |
64.41±24.78 |
71.76±24.30 |
Time |
12868.12 |
2 |
6364.06 |
28.09 |
<.001 |
|
AcuKT (n=27) |
58.22±21.23 |
72.29±23.30 |
79.28±16.16 |
Group*Time |
0.96 |
2 |
1.97 |
0.002 |
.998 |
|
Acu, acupuncture
There were no significant differences in all variables between the two groups with respect to VAS-pain, edema, EQ–5D–5L, and FAOS (Week 0 vs. Week 1, Week 0 vs. Week 5, and Week 1 vs. Week 5) (Table4).
Table 4. Comparison of changes in outcome measurements between patients who received AcuKT (n=27) and those who received acupuncture (n=29) for acute lateral ankle sprain
|
Dependent Vatiables |
Group (n) |
Week 0 (M±SD) |
Difference (w1-w0) |
Z(p) * |
Difference (w5-w0) |
Z(p) * |
Difference (w5-w1) |
Z(p) * |
|
VAS of pain |
Acu(n=29) |
4.79±2.02 |
-2.47±1.86 |
-0.25 (.804) |
-3.21±1.99 |
-0.52 (.603) |
-0.74±1.23 |
-0.72 (.471) |
|
AcuKT(n=27) |
4.11±1.40 |
-2.21±1.58 |
-3.14±1.34 |
-0.93±1.07 |
||||
|
Degree of edema |
Acu(n=29) |
0.48±0.78 |
-0.24± 0.64 |
-0.50 (.620) |
-0.22±0.60 |
-1.11 (.269) |
0.02±0.44 |
-0.87 (.386) |
|
AcuKT(n=27) |
0.56±0.64 |
-0.30± 0.54 |
-0.36±0.68 |
-0.07±0.52 |
||||
|
TOTAL EQ-5D-5L |
Acu(n=29) |
9.90±2.83 |
-2.14±2.50 |
-0.11 (.914) |
-2.90±2.54 |
-0.95 (.341) |
-0.76±1.81 |
-0.58 (561) |
|
AcuKT(n=27) |
9.41±2.37 |
-2.22±3.06 |
-3.37±2.68 |
-1.15±1.66 |
||||
|
TOTAL FAOS |
Acu(n=29) |
318.32±76.72 |
66.67±49.51 |
-0.30 (.762) |
97.92±73.06 |
-0.71 (.476) |
31.25±40.88 |
-0.86 (.389) |
|
AcuKT(n=27) |
322.11±65.78 |
80.33±62.74 |
117.54±61.29 |
37.21±41.42 |
||||
|
FAOS Symptom/Rigidity |
Acu(n=29) |
69.91±16.52 |
12.19±12.38 |
-0.67 (.948) |
16.39±14.59 |
-0.97 (.332) |
4.19±10.65 |
-1.05 (.295) |
|
AcuKT(n=27) |
68.01±14.46 |
13.43±12.82 |
21.00±16.70 |
7.57±11.04 |
||||
|
FAOS ache |
Acu(n=29) |
68.24±17.18 |
12.66±11.09 |
-0.49 (.622) |
17.93±15.55 |
-1.03 (.301) |
5.27±9.16 |
-0.85 (.396) |
|
AcuKT(n=27) |
69.39±15.52 |
15.02 13.59 |
22.53±14.57 |
7.51±8.68 |
||||
|
FAOS Function, everyday life |
Acu(n=29) |
77.38±16.17 |
9.68 11.05 |
-0.85 (.398) |
14.99±14.05 |
-1.31 (.189) |
5.31±10.05 |
-0.33 (.736) |
|
AcuKT(n=27) |
75.93±14.75 |
14.09 13.20 |
19.07±13.90 |
4.98±6.32 |
||||
|
FAOS Features,Sports/ Leisure |
Acu(n=29) |
52.17±19.99 |
18.35 18.75 |
-0.87 (.382) |
27.49±22.91 |
-0.86 (.388) |
9.14±12.11 |
-0.35 (.728) |
|
AcuKT(n=27) |
50.56±25.34 |
23.72±20.09 |
33.87±20.47 |
10.16±13.59 |
||||
|
FAOS Quality of life |
Acu(n=29) |
50.63±25.35 |
13.79±21.42 |
-0.03 (.974) |
21.13±22.93 |
-0.17 (.869) |
7.34±16.47 |
-0.23 (.817) |
|
AcuKT(n=27) |
58.22±21.23 |
14.07±22.22 |
21.06±21.43 |
6.99±23.42 |
Acu, acupuncture; *, Mann-Whitney U-test
A subanalysis based on the severity of ankle sprain showed no significant differences in all variables between the two groups in the Grade I and Grade II groups (Tables 5 and 6).
Table 5. Comparison of changes in outcome measurement between patients who received AcuKT (n=13) and those who received acupuncture (n=16) for Grade I acute lateral ankle sprain
|
Dependent Vatiables |
Group (n) |
Week 0 (M±SD) |
Week 1 (M±SD) |
Week 5 (M±SD) |
Difference (w1-w0) |
Z(p)* |
Difference (w5-w0) |
Z(p)* |
Difference (w5-w1) |
Z(p)* |
|
VAS of pain |
Acu (n=16) |
4.33±1.82 |
2.32±1.91 |
1.79±2.07 |
-2.01±1.96 |
-0.84 (.400) |
-2.54±2.13 |
-0.80 (.426) |
-0.53±1.38 |
-0.73 (.463) |
|
AcuKT (n=13) |
4.34±1.56 |
1.97±1.85 |
1.12±1.13 |
-2.37±1.84 |
-3.08±1.45 |
-0.85±1.13 |
||||
|
Degree of edema |
Acu (n=16) |
0.44±0.89 |
0.31±0.79 |
0.28±0.74 |
-0.13±0.72 |
-0.38 (.704) |
-0.16±0.64 |
-0.53 (.600) |
-0.03±0.26 |
-0.24 (.893) |
|
AcuKT (n=13) |
0.23±0.60 |
0.08±0.49 |
0.11±0.29 |
-0.15±0.38 |
-0.11±0.51 |
0.03±0.51 |
||||
|
TOTAL EQ-5D-5L |
Acu (n=16) |
9.19±1.60 |
7.69±2.47 |
6.81±2.11 |
-1.50±2.34 |
-0.45 (.655) |
-2.38±2.45 |
-0.33 (.739) |
-0.88±1.96 |
-0.48 (.630) |
|
AcuKT (n=13) |
8.77±2.39 |
6.85±2.08 |
6.31±1.75 |
-1.92±3.12 |
-2.50±2.62 |
-0.54±1.13 |
||||
|
TOTAL FAOS |
Acu (n=16) |
331.69±43.64 |
395.62±74.82 |
411.52±81.83 |
63.93±59.95 |
-0.44 (.661) |
79.83±71.06 |
-0.44 (.661) |
15.90±22.40 |
-0.66 (.511) |
|
AcuKT (n=13) |
349.06±43.64 |
429.66±48.30 |
440.15±48.82 |
81.37±61.03 |
95.26±43.07 |
10.49±37.59 |
||||
|
FAOS Symptom/Rigidity |
Acu (n=16) |
73.61±11.58 |
83.67±11.66 |
85.23±13.18 |
10.06±11.46 |
-0.88 (.378) |
11.61±12.27 |
-1.92 (.055) |
1.56±8.56 |
-1.24 (.216) |
|
AcuKT (n=13) |
69.19±14.04 |
84.03±12.53 |
90.90±8.20 |
14.84±9.09 |
21.35±13.48 |
6.87±9.52 |
||||
|
FAOS ache |
Acu (n=16) |
70.78±13.97 |
83.47±14.85 |
85.91±18.06 |
12.69±12.23 |
-0.07 (.947) |
15.13±15.23 |
-0.04 (.965) |
2.44±7.17 |
-0.58 (.562) |
|
AcuKT (n=13) |
75.80±16.68 |
88.22±11.42 |
90.79±10.43 |
12.42±10.61 |
15.79±12.04 |
2.56±7.74 |
||||
|
FAOS Function, everyday life |
Acu (n=16) |
79.36±9.95 |
90.31±11.54 |
90.88±12.74 |
10.9±9.79 |
-0.22 (.826) |
11.52±10.87 |
-0.42 (.677) |
0.57±3.54 |
-0.42 (.673) |
|
AcuKT (n=13) |
79.48±17.97 |
92.83±10.15 |
94.66±7.64 |
13.35±14.40 |
14.33±16.08 |
1.83±5.41 |
||||
|
FAOS Features,Sports/ Leisure |
Acu (n=16) |
52.50±13.29 |
72.19±19.06 |
78.44±20.31 |
19.69±22.02 |
-0.86 (.390) |
25.94±24.51 |
-0.18 (.860) |
6.25±9.75 |
-1.03 (.304) |
|
AcuKT (n=13) |
54.62±17.61 |
80.77±17.89 |
83.08±16.01 |
26.92±17.97 |
29.23±14.41 |
2.31±12.18 |
||||
|
FAOS Quality of life |
Acu (n=16) |
55.45±25.10 |
65.99±26.21 |
71.08±28.86 |
10.54±22.56 |
-0.22 (.826) |
15.63±24.36 |
-0.13 (.895) |
5.09±8.60 |
-1.09 (.278) |
|
AcuKT (n=13) |
69.98±14.42 |
83.81±20.45 |
80.73±13.41 |
13.83±23.40 |
12.79±19.00 |
-3.08±27.89 |
Acu, acupuncture; *, Mann-Whitney U-test
Table 6. Comparison of changes in outcome measurements between patients who received AcuKT (n=14) and those who received acupuncture (n=13) for Grade II acute lateral ankle sprain
|
Dependent Vatiables |
Group (n) |
Week 0 (M±SD) |
Week 1 (M±SD) |
Week 5 (M±SD) |
Difference (w1-w0) |
Z(p)* |
Difference (w5-w0) |
Z(p)* |
Difference (w5-w1) |
Z(p)* |
|
VAS of pain |
Acu (n=13) |
5.35±2.17 |
2.31±1.89 |
1.32±1.70 |
-3.04±1.61 |
-1.37 (.170) |
-4.03±1.51 |
-1.73 (.083) |
-0.99±1.01 |
-0.22 (.825) |
|
AcuKT (n=14) |
3.90±1.26 |
1.83±1.01 |
0.83±0.96 |
-2.07±1.34 |
-3.07±1.32 |
-1.00±1.05 |
||||
|
Degree of edema |
Acu (n=13) |
0.54±0.66 |
0.15±0.69 |
0.23±0.27 |
-0.38±0.51 |
-0.36 (.720) |
-0.31±0.56 |
-1.18 (.240) |
0.08±0.60 |
-1.06 (.287) |
|
AcuKT (n=14) |
0.86±0.53 |
0.43±0.65 |
0.27±0.52 |
0.43±0.65 |
-0.59±0.75 |
-0.16±0.53 |
||||
|
TOTALEQ5D5L |
Acu (n=13) |
10.77±3.75 |
7.85±2.23 |
7.23±2.35 |
-2.92±2.56 |
-0.79 (.430) |
-3.54±2.60 |
-0.88 (.378) |
-0.62±1.66 |
-1.30 (.193) |
|
AcuKT (n=14) |
10.00±2.29 |
7.50±1.83 |
5.79±1.12 |
-2.50±3.08 |
-4.21±2.42 |
-1.71±1.90 |
||||
|
TOTALFAOS |
Acu (n=13) |
301.87±104.02 |
371.92±82.61 |
422.07±66.53 |
70.05±34.70 |
-0.05 (.961) |
120.20±71.90 |
-0.44 (.662) |
50.15±50.70 |
-1.02 (.308) |
|
AcuKT (n=14) |
297.09±63.25 |
377.16±60.33 |
439.18±53.42 |
78.74±67.66 |
140.75±68.84 |
62.01±27.40 |
||||
|
FAOS Symptom/Rigidity |
Acu (n=13) |
2.62±0.87 |
80.18±16.62 |
87.62±14.33 |
14.82±13.42 |
-0.63 (.527) |
22.26±15.51 |
-0.37 (.715) |
7.44±12.34 |
-0.20 (.845) |
|
AcuKT (n=14) |
2.29±0.61 |
79.04±11.74 |
87.26±13.10 |
12.13±15.77 |
20.35±19.42 |
8.22±12.61 |
||||
|
FAOS ache |
Acu (n=13) |
65.35±20.69 |
77.75±17.68 |
86.50±14.65 |
12.62±9.99 |
-0.75 (.451) |
21.38±15.85 |
-1.31 (.189) |
8.75±10.38 |
-1.10 (.273) |
|
AcuKT (n=14) |
66.91±15.28 |
80.87±11.31 |
92.98±7.59 |
17.43±15.89 |
29.54±13.37 |
12.11±6.94 |
||||
|
FAOS Function,everydaylife |
Acu (n=13) |
65.12±20.62 |
83.06±15.78 |
94.21±8.48 |
8.12±12.65 |
-0.80 (.423) |
19.26±16.65 |
-1.07 (.285) |
11.15±12.38 |
-0.17 (.865) |
|
AcuKT (n=14) |
63.44±12.07 |
87.42±10.15 |
95.32±5.99 |
14.78±12.49 |
22.68±10.44 |
7.90±5.81 |
||||
|
FAOS Features,Sports/Leisure |
Acu (n=13) |
51.75±26.67 |
68.46±23.04 |
81.15±14.88 |
16.71±14.47 |
-0.39 (.697) |
29.40±21.59 |
-1.07 (.284) |
12.69±14.09 |
-1.10 (.271) |
|
AcuKT (n=14) |
46.79±23.42 |
68.24±14.74 |
85.69±13.57 |
21.46±21.55 |
38.90±24.48 |
17.44±10.66 |
||||
|
FAOS Qualityoflife |
Acu (n=13) |
44.69±25.36 |
62.48±23.80 |
72.59±18.32 |
17.78±20.08 |
-0.34 (.733) |
27.90±19.88 |
-0.05 (.961) |
10.12±22.91 |
-0.57 (.558) |
|
AcuKT (n=14) |
47.30±21.06 |
61.59±21.06 |
77.93±18.77 |
14.29±23.81 |
29.29±22.52 |
16.34±13.54 |
Acu, acupuncture; *, Mann-Whitney U-test
Regarding the number of recurrent ankle sprains (at Week 5, Week 9, Week 13, and Week 27) and the changes in EQ–5D–5L (Week 0 vs. Week 27), there were no significant differences between the two groups (Tables 7 and 8).
Table 7. Comparisons of number of recurrences at different time points between patients who received AcuKT (n=27) and those who received acupuncture (n=29) for acute lateral ankle sprain
|
Dependent Vatiables |
AcuKT(n=27) (M±SD) |
Acu(n=29) (M±SD) |
z(p) * |
|
Total Relapse |
0.33±1.62 |
1.03±2.86 |
-1.11(.268) |
|
Week 5 Relapse |
-0.04±1.06 |
0.31±1.07 |
-1.33(.185) |
|
Week 9 Relapse |
0.00±0.48 |
0.34±0.86 |
-1.44(.149) |
|
Week 13 Relapse |
0.22±0.64 |
0.31±0.76 |
-0.31(.758) |
|
Week 27 Relapse |
0.15±0.82 |
0.07±0.75 |
-0.62(.535) |
Acu, acupuncture; *, Mann-Whitney U-test
Table 8. Comparison of changes in EQ-5D-5L scores from baseline to 26 weeks after treatment between patients who received AcuKT (n=27) and those who received acupuncture (n=29) for acute lateral ankle sprain
|
Dependent Vatiables |
Group (n) |
Week 0 (M±SD) |
Week 27 (M±SD) |
Difference (w27-w0 ) |
Z(p)* |
|
TOTAL EQ-5D-5L |
Acu(n=29) |
9.90±2.83 |
6.07±2.48 |
-3.83±3.43 |
-0.58 (.954) |
|
AcuKT(n=27) |
9.41±2.37 |
5.52±1.37 |
-3.89±2.79 |
Acu, acupuncture; *, Mann-Whitney U-test
Adverse events that occurred in this study were recorded on a case report form after evaluating their relationships with the intervention. No adverse events that were related to the intervention occurred in this study.
To the best of our knowledge, this is the first randomized controlled study to investigate the add-on effects of KT on acupuncture in terms of pain reduction, edema, recovery of function, activities of daily living, quality of life, and relapse of ALAS, by comparing the effects of AcuKT with the effects of acupuncture alone. The design of our study (i.e., 1-week duration of treatment, acupoint selected for acupuncture, and KT treatment method) was determined with reference to a previous study [1,9,28]. We observed significant improvements in the AcuKT group and acupuncture group (i.e., changes in VAS-pain, EQ–5D–5L, Total FAOS, FAOS Symptom/Rigidity, FAOS Ache, FAOS Function everyday life, FAOS Features Sports/Leisure, and FAOS Quality of life scores).
There were two major findings in our study. First, AcuKT did not show positive add-on effects of KT on acupuncture in terms of pain reduction, edema, recovery of function, activities of daily living, quality of life, and relapse of ALAS. Second, a subanalysis considering the severity of ankle sprain demonstrated no positive add-on effects of KT on acupuncture in terms of pain reduction, edema, recovery of function, activities of daily living, quality of life, and relapse of patients with ALAS.
There are several explanations for our results. First, there is conflicting evidence regarding the efficacy of KT in the prevention and management of ankle sprain. Three systematic reviews reported that KT demonstrated little clinical significance or effect on ankle movement and various measures of strength compared to usual care or sham tape [29–31]. However, a systematic review showed that KT produced an immediate reduction in pain [29]. Further, other systematic reviews reported that KT demonstrated small improvements in movement and muscle activity [32], and that KT could be used for the prevention and management of lateral ankle injuries [33]. Conflicting findings from these systematic reviews may be caused by insufficient high-quality evidence, and heterogeneity of participants, interventions (i.e., applied KT technique), and outcome measures. The efficacy of KT for ankle sprain may be different depending on the design of clinical trials. Second, the intervention that is combined with KT may affect the results. In previous studies that showed a positive add-on effect of KT on ankle sprain [28, 34], KT was combined with physiotherapy. However, we selected acupuncture because KT is mainly used with acupuncture in Korean medicine. Third, we applied the ankle meridian tendino-musculature and eight-shape-form KT treatment, which was used in a previous study [20]. However, several different techniques have been adopted in previous studies that show a positive effect of KT on ankle sprain, whereas only one was used in our study [28, 34–36]. Fourth, the inclusion criteria of this study included the occurrence of Grade I or II ALAS within previous 7 days. The absence of high-quality evidence to inform effective management of ankle sprains in acute care settings is related largely to perceptions that Grade I and II ankle sprains are relatively benign injuries [37]. In a previous randomized controlled trial, there was no significant add-on effect of supervised physiotherapy on usual care in patients with Grade I and II ankle sprain [38].
This study had some limitations. First, we adopted a single outcome assessor-blinding approach because sham treatment was impossible given the characteristics of KT application. This limitation may have led to a bias in the results of the study. Second, this study was performed to investigate the add-on effect of KT on ankle sprain by comparing AcuKT with acupuncture alone. However, there are various conventional treatments (e.g., usual care and physiotherapy) for ankle sprain. Therefore, studies investigating the add-on effect of KT on various conventional treatments or the effect of KT alone may be beneficial. Third, we did not investigate the add-on effect of KT through various ankle KT methods. There are several different techniques for treating lateral ankle sprains. However, we used only ankle meridian tendino-musculature and the eight-shape form of KT treatment. Thus, further studies of an effective treatment method of KT seem necessary. Fourth, our findings were limited to acute Grade I or II ALAS. Further studies should analyze the effect of KT in patients with chronic stage or Grade III ALAS.
According to our results, there were no significant differences between the two treatments. AcuKT did not show positive add-on effects of KT on acupuncture in terms of pain reduction, edema, recovery of function, activities of daily living, quality of life, and relapse of ALAS. We believe the results of our study could have varied greatly depending on subject characteristics (time after injury and level of severity), KT treatment method, and intervention combination. Therefore, additional studies aimed at investigating possible positive add-on effects of KT in combination with different treatments and different settings remain to be conducted in the future.
AcuKT, acupuncture combined with Kinesiotape; ALAS, acute lateral ankle sprain; ANOVA, analysis of variance; CONSORT, Consolidated Standards of Reporting Trials; EQ–5D–5L, European Quality of Life Five Dimension-Five Level Scale; FAOS, Foot and Ankle Outcome Score; IRB, Institutional Review Board; KT, Kinesiotape; SPIRIT, Standard Protocol Items of the Recommendations for Interventional Trials; VAS, visual analog scale.
This study was conducted in accordance with the Declaration of Helsinki and the protocol of this study (ver.1.0) was approved by the Institutional Review Board (IRB) of DongShin University Gwangju Korean Medicine Hospital (DSGOH–039; approval date: March 20, 2017), DongShin University Mokpo Oriental Hospital (DSMOH–002; approval date: March 27, 2017), and KyungHee Korean Medicine Hospital (KOMCIRB–161014-HR–057; approval date: April 28, 2017) before the trial began. This trial was registered at the Clinical Research Information Service (cris.nih.go.kr; registration number: KCT0002257; registration date: February 27, 2017). The purpose and potential risks of this study were fully explained to the participants. All participants provided written informed consent before participating in this study.
Written informed consent for publication of individual details and accompanying images will be obtained from the trial participants. The consent forms are in the possession of the authors and are available for review by the Editor-in-Chief.
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
The authors declare that they have no conflicts of interest concerning this article.
This study was supported by the Traditional Korean Medicine R&D program funded by the Ministry of Health and Welfare through the Korea Health Industry Development Institute (KHIDI) (https://www.khidi.or.kr/kps) (HB16C0026). This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) (https://www.khidi.or.kr/kps) funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI18C0546). The funder had no role in the design of the study and data collection, analysis, interpretation, decision to publish, and preparation of the manuscript.
JCS and JHK designed and conceptualized the trial, wrote the initial draft, and analyzed data. JCS, JHK, DN, and GCP designed the trial and conducted the trial. JSL is responsible for planning the data analysis and interpreting the data resulting from the trial. All authors read, revised the manuscript, and approved the final manuscript.
The authors express their sincere thanks to their colleagues and the staff at DongShin University Gwangju Korean Medicine Hospital, DongShin University Mokpo Oriental Hospital, and KyungHee Korean Medicine Hospital for their support.